Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTAW) Change in Intangibles (2021 - 2025)

Historic Change in Intangibles for Strata Critical Medical (SRTAW) over the last 3 years, with Q3 2025 value amounting to $297000.0.

  • Strata Critical Medical's Change in Intangibles fell 5082.78% to $297000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 343.37%. This contributed to the annual value of $2.1 million for FY2024, which is N/A changed from last year.
  • Per Strata Critical Medical's latest filing, its Change in Intangibles stood at $297000.0 for Q3 2025, which was down 5082.78% from $429000.0 recorded in Q2 2025.
  • Strata Critical Medical's Change in Intangibles' 5-year high stood at $12.4 million during Q4 2021, with a 5-year trough of -$503000.0 in Q3 2021.
  • Moreover, its 3-year median value for Change in Intangibles was $459000.0 (2024), whereas its average is $1.7 million.
  • Examining YoY changes over the last 5 years, Strata Critical Medical's Change in Intangibles showed a top increase of 7106.11% in 2025 and a maximum decrease of 5082.78% in 2025.
  • Quarter analysis of 3 years shows Strata Critical Medical's Change in Intangibles stood at $12.4 million in 2021, then plummeted by 96.29% to $459000.0 in 2024, then crashed by 35.29% to $297000.0 in 2025.
  • Its last three reported values are $297000.0 in Q3 2025, $429000.0 for Q2 2025, and $532000.0 during Q1 2025.